XORTX Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -25 | -29 | -29 | -28 |
EBITDA | -797 | -657 | -686 | -862 |
EBIT | -823 | -686 | -716 | -889 |
Net Income | -808 | -590 | -649 | -717 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -505 | -726 | -635 | -815 |
Cash | 251 | 864 | 1,193 | 1,063 |
Basic Shares | 13 | 262 | 194 | 151 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -114 | -111 | -141 | -74 |
EBITDA | -3,143 | -3,042 | -6,014 | -9,410 |
EBIT | -3,256 | -3,154 | -6,156 | -9,485 |
Net Income | -2,656 | -3,154 | -2,859 | -6,988 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,817 | -3,502 | -6,629 | -9,009 |
Cash | 862 | 2,472 | 3,447 | 10,434 |
Basic Shares | 189 | 115 | 79 | 59 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.58 |
2025-12-31 | -$0.09 |
2025-09-30 | -$0.13 |
2025-06-30 | -$0.19 |